Suppliers / Farmson Basic Drugs

Farmson Basic Drugs

India 528 employees Updated 9 July 2026

Farmson Basic Drugs is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by EMA. Customs aggregates show $38.3M of exports covering 815 molecules to 58 destinations in 2025.

1
active US DMFs
1
valid CEPs
3
registered plants 3 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Bharuch, India 3019101447
Vadodara, India 3013841460
Vadodara, India 3017116839

What they file, and where

Molecule Regulators Docs
Acetaminophen EDQM, US FDA 2

Also appears on these molecule pages

Paracetamol API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA None 2

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $5.8M 28
2025 Not reported $38.3M 58
2024 Not reported $9.4M 31

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Farmson Basic Drugs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts